These associations may be due to residual confounding, in that people with diabetes or who received IL-6 inhibitors might represent sub-populations with more severe COVID-19 who thus might stay in hospital for longer, leading to increased antibiotic use. This evidence concerns the gene IL6 and COVID-19.